NL171986C - Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen. - Google Patents

Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen.

Info

Publication number
NL171986C
NL171986C NLAANVRAGE7216621,A NL7216621A NL171986C NL 171986 C NL171986 C NL 171986C NL 7216621 A NL7216621 A NL 7216621A NL 171986 C NL171986 C NL 171986C
Authority
NL
Netherlands
Prior art keywords
medicinal products
benzodiazepine
aza
preparing
manufacturing
Prior art date
Application number
NLAANVRAGE7216621,A
Other languages
English (en)
Other versions
NL171986B (nl
NL7216621A (nl
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of NL7216621A publication Critical patent/NL7216621A/xx
Publication of NL171986B publication Critical patent/NL171986B/nl
Application granted granted Critical
Publication of NL171986C publication Critical patent/NL171986C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
NLAANVRAGE7216621,A 1971-12-09 1972-12-07 Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen. NL171986C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1060471A AT333284B (de) 1971-12-09 1971-12-09 Verfahren zur herstellung von neuen 6-aza-3h-1,4-benzodiazepinen, deren optischen isomeren und deren salzen

Publications (3)

Publication Number Publication Date
NL7216621A NL7216621A (nl) 1973-06-13
NL171986B NL171986B (nl) 1983-01-17
NL171986C true NL171986C (nl) 1983-06-16

Family

ID=3623479

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7216621,A NL171986C (nl) 1971-12-09 1972-12-07 Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen.

Country Status (26)

Country Link
JP (4) JPS569509B2 (nl)
AR (3) AR201201A1 (nl)
AT (4) AT332877B (nl)
AU (1) AU473253B2 (nl)
BE (1) BE792541A (nl)
CH (4) CH594665A5 (nl)
CS (1) CS212736B2 (nl)
DD (1) DD105448A5 (nl)
DE (1) DE2259471C2 (nl)
DK (1) DK138425B (nl)
EG (1) EG10918A (nl)
ES (2) ES409090A1 (nl)
FI (1) FI54710C (nl)
FR (1) FR2162482B1 (nl)
GB (1) GB1400755A (nl)
HU (1) HU169468B (nl)
IL (1) IL41034A (nl)
IT (1) IT1035053B (nl)
NL (1) NL171986C (nl)
NO (1) NO137094C (nl)
PL (3) PL91876B1 (nl)
RO (4) RO65263A (nl)
SE (1) SE404803B (nl)
SU (4) SU468423A3 (nl)
YU (2) YU305972A (nl)
ZA (1) ZA728497B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364636C2 (de) * 1973-12-24 1982-11-04 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 2-Benzoyl-6-chlor-3-nitro-pyridinen
EP0032516B1 (en) * 1980-01-16 1984-05-02 Lacer, S.A. New 2-halo-pyridines, their production and pharmaceutical compositions
JPS60132610A (ja) * 1983-12-20 1985-07-15 Japan Organo Co Ltd 汚泥脱水装置
JPS6219221A (ja) * 1985-07-16 1987-01-28 Chiyoda Chem Eng & Constr Co Ltd 原液中の微細粒子を除去する濾過方法と濾過装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314941A (en) * 1964-06-23 1967-04-18 American Cyanamid Co Novel substituted pyridodiazepins
US3523939A (en) * 1967-07-03 1970-08-11 Hoffmann La Roche 5-(2,6-disubstituted phenyl)-1,4-benzodiazepines and methods for their preparation

Also Published As

Publication number Publication date
SU468423A3 (ru) 1975-04-25
PL91828B1 (en) 1977-03-31
JPS5742638B2 (nl) 1982-09-09
ZA728497B (en) 1973-09-26
PL91876B1 (en) 1977-03-31
DE2259471C2 (de) 1982-08-19
GB1400755A (en) 1975-07-23
RO67345A (ro) 1980-07-15
FR2162482B1 (nl) 1976-03-05
SU564809A3 (ru) 1977-07-05
JPS569509B2 (nl) 1981-03-02
RO65264A (fr) 1979-08-15
BE792541A (fr) 1973-06-08
SU574156A3 (ru) 1977-09-25
FI54710B (fi) 1978-10-31
IL41034A0 (en) 1973-02-28
CH603645A5 (nl) 1978-08-31
JPS5742639B2 (nl) 1982-09-09
AU473253B2 (en) 1976-06-17
YU305972A (en) 1982-02-28
JPS4864096A (nl) 1973-09-05
IL41034A (en) 1976-10-31
JPS5625181A (en) 1981-03-10
ATA1060471A (de) 1976-03-15
HU169468B (nl) 1976-11-28
AT332877B (de) 1976-10-25
YU116881A (en) 1984-02-29
ES409089A1 (es) 1975-10-16
PL89682B1 (en) 1976-12-31
RO65263B (ro) 1983-06-30
DD105448A5 (nl) 1974-04-20
AT332878B (de) 1976-10-25
AT338798B (de) 1977-09-12
SU674675A3 (ru) 1979-07-15
CS212736B2 (en) 1982-03-26
ATA902174A (de) 1976-02-15
CH603644A5 (nl) 1978-08-31
JPS5625180A (en) 1981-03-10
CH594665A5 (nl) 1978-01-13
DK138425B (da) 1978-09-04
ATA902274A (de) 1976-02-15
SE404803B (sv) 1978-10-30
AT333284B (de) 1976-11-10
DE2259471A1 (de) 1973-06-14
NL171986B (nl) 1983-01-17
ATA902074A (de) 1977-01-15
JPS55147282A (en) 1980-11-17
CH605946A5 (nl) 1978-10-13
FR2162482A1 (nl) 1973-07-20
RO62312A (fr) 1977-12-15
NO137094C (no) 1977-12-28
AR203311A1 (es) 1975-08-29
JPS5744678B2 (nl) 1982-09-22
NL7216621A (nl) 1973-06-13
DK138425C (nl) 1979-02-12
AR200309A1 (es) 1974-10-31
FI54710C (fi) 1979-02-12
EG10918A (en) 1981-12-31
AR201201A1 (es) 1975-02-21
IT1035053B (it) 1979-10-20
AU4993172A (en) 1974-06-13
NO137094B (no) 1977-09-19
ES409090A1 (es) 1975-10-16
RO65263A (ro) 1983-07-07

Similar Documents

Publication Publication Date Title
NL178965C (nl) Werkwijze voor de bereiding van geneesmiddelen met beta-adrenolytische werking, gevormde geneesmiddelen die deze bevatten, en werkwijze voor de bereiding van verbindingen met deze werking.
NL7416022A (nl) Werkwijze voor het bereiden van een geneesmid- del, zo gevormd geneesmiddel en werkwijze ter bereiding van de daartoe vereiste geneeskrach- tige verbindingen.
NL166939C (nl) Werkwijze voor het bereiden van geneesmiddelen met een gunstige invloed op de bloedsomloop, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve verbindingen.
NL173641C (nl) Werkwijze voor het bereiden of vervaardigen van een geneesmiddel.
NL169262C (nl) Werkwijze voor het conserveren van plantaardige produkten, alsmede werkwijze voor het bereiden van een daarbij gebruikt conserveermiddel.
NL181801C (nl) Werkwijze voor het bereiden van geneeskrachtige verbindingen op basis van 1,1-difenyletheenderivaten, en voor de bereiding van geneesmiddelen, die deze verbindingen bevatten.
NL7700637A (nl) Werkwijze voor het bereiden van gestogeenesters, alsmede geneesmiddelen, die deze esters bevatten.
NL161444C (nl) Werkwijze voor de bereiding van een geneesmiddel met an- ti-arrhytmische werking, gevormd geneesmiddel met een degelijke werking en werkwijze voor de bereiding van een ureumderivaat.
NL152171B (nl) Werkwijze voor het bereiden van een geneesmiddel met vaatverwijdende eigenschappen, alsmede gevormd geneesmiddel.
NL151404B (nl) Werkwijze voor het bereiden van een polyester, alsmede daarvan vervaardigd gevormd voortbrengsel.
NL170733C (nl) Werkwijze voor het bereiden of vervaardigen van een geneesmiddel en werkwijze voor het bereiden van een geneeskrachtige verbinding.
NL171986C (nl) Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen.
NL7601019A (nl) Werkwijze voor de bereiding van 5h-di- benzo (a,d) cyclohepteencarbonamiden en 10,11-di- hydro-5h-dibenzo (a,d)-cyclohepteencarbonamiden, een werkwijze voor de bereiding van een geneesmid- del met anti-arytmische en anti-hypertensieve wer- king alsmede een dergelijk geneesmiddel.
NL176142C (nl) Werkwijze voor het bereiden van pijnstillende en ontstekingsremmende geneesmiddelen, alsmede een daarvoor geschikt acetylsalicylzuur houdend coprecipitaat.
NL161150C (nl) Werkwijze voor het bereiden van een geneesmiddel, alsmede verkregen gevormd geneesmiddel en werkwijze voor het bereiden van een benzofuranverbinding.
NL7312032A (nl) Werkwijze voor het bereiden en toedienen van een diergeneesmiddel.
NL174944C (nl) Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met antibiotische werkzaamheid, alsmede werkwijze voor het bereiden van een hetacilline verbinding.
NL152585B (nl) Werkwijze voor de bereiding van een siloxancopolymeer, werkwijze voor het bereiden van schuimstoffen, alsmede de daaruit vervaardigde voorwerpen.
NL151994B (nl) Werkwijze voor de bereiding van cefalosporine met antibiotische werking, werkwijze voor de bereiding van een geneesmiddel met een dergelijke werking en gevormd geneesmiddel.
NL7408875A (nl) Werkwijze voor de bereiding van alkalipolyfos- faatcomplexen met antibiotische werking, werk- wijze voor de bereiding van een geneesmiddel met een dergelijke werking en een dergelijk geneesmiddel.
NL177309C (nl) Werkwijze voor de bereiding van een geneesmiddel en werkwijze voor de bereiding van 1-gesubstitueerde pyrazoolverbindingen.
NL157314B (nl) Werkwijze voor het bereiden van een 3-oxo-13beta-r-17alfa-x, 17beta-hydroxy-gona-4,9,11-trieen, alsmede werkwijze voor het bereiden van een geneesmiddel en onder toepassing daarvan verkregen gevormd geneesmiddel.
NL179056C (nl) Werkwijze voor het bereiden van geneesmiddelen met een anti-allergische en ontstekingsremmende activiteit, alsmede daarvoor geschikte, geneeskrachtige verbindingen.
NL7416074A (nl) Werkwijze voor het bereiden van 1-amino-5,6-di- hydro-morfanthridin-5,11-dion-verbindingen, werkwijze voor het bereiden van geneesmiddelen, alsmede de gevormde geneesmiddelen.
NL169177C (nl) Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met werking op het cardiovasculaire systeem, alsmede werkwijze voor het bereiden van daarvoor geschikte geneeskrachtige arylalkylamidinederivaten.

Legal Events

Date Code Title Description
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: DEGUSSA AKTIENGESELLSCHAFT

V1 Lapsed because of non-payment of the annual fee